Dr. Brandon Smaglo, MD

Claim this profile

M D Anderson Cancer Center

Studies Pancreatic Cancer
Studies KRAS Mutation
4 reported clinical trials
11 drugs studied

Area of expertise

1

Pancreatic Cancer

Brandon Smaglo, MD has run 3 trials for Pancreatic Cancer. Some of their research focus areas include:

KRAS positive
Stage IV
Stage I
2

KRAS Mutation

Brandon Smaglo, MD has run 1 trial for KRAS Mutation. Some of their research focus areas include:

KRAS positive
Stage IV

Affiliated Hospitals

Image of trial facility.

M D Anderson Cancer Center

Clinical Trials Brandon Smaglo, MD is currently running

More about Brandon Smaglo, MD

Clinical Trial Related

3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Brandon Smaglo, MD has experience with

  • Mesenchymal Stromal Cells-derived Exosomes With KRAS G12D SiRNA
  • Durvalumab
  • Gemcitabine
  • Nab-paclitaxel
  • Oleclumab
  • Lenvatinib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Brandon Smaglo, MD specialize in?

Is Brandon Smaglo, MD currently recruiting for clinical trials?

Are there any treatments that Brandon Smaglo, MD has studied deeply?

What is the best way to schedule an appointment with Brandon Smaglo, MD?

What is the office address of Brandon Smaglo, MD?

Is there any support for travel costs?